NCT01293110 Lower Urinary Tract Dysfunction Database
| NCT ID | NCT01293110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Zurich |
| Condition | Neurogenic Bladder |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2010-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2010-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with neurological disease/injury often suffer from lower urinary tract symptoms, which frequently have a negative impact on the patients' health related quality of life. The prevalence of lower urinary tract dysfunction is high and the treatment is a challenge because available treatments may fail. In this study data of patients with lower urinary tract dysfunction treated at the University of Zürich, are prospectively and systematically collected in a database.
Eligibility Criteria
Inclusion Criteria: * patient of Balgrist University Hospital * patient of University Hospital Zürich * urodynamic examination * written informed consent Exclusion Criteria: * no written informed consent
Contact & Investigator
Thomas M Kessler
PRINCIPAL INVESTIGATOR
Universitätsklinik Balgrist
Frequently Asked Questions
Who can join the NCT01293110 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Neurogenic Bladder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01293110 currently recruiting?
Yes, NCT01293110 is actively recruiting participants. Contact the research team at thomas.kessler@balgrist.ch for enrollment information.
Where is the NCT01293110 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT01293110 clinical trial?
NCT01293110 is sponsored by University of Zurich. The principal investigator is Thomas M Kessler at Universitätsklinik Balgrist. The trial plans to enroll 7,000 participants.